Korea

AXIS-Y Marks a Remarkable 95% Sales Growth: Leading the Way in K-Beauty Innovation

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- In an astonishing display of growth and innovation, AXIS-Y, a frontrunner in the K-beauty industry, has announced a staggering 95% increase in sales compared to the previous year. This milestone underscores the brand's formidable presence in the gl...

2024-02-06 11:06 2745

SK hynix Unveils Roadmap for Use of Recycled Materials

* Aims to increase the percentage of recycled materials to 25% by 2025, above 30% by 2030 * Sets goals and action plans, while encouraging participation from partners * Moves towards a circular economy by joining forces with all stakeholders SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- S...

2024-02-06 08:00 2922

Rokit Healthcare Scores High Marks in KOSDAQ Tech Listing Evaluation

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- Rokit Healthcare, a trailblazer in AI-driven medical bioprinting technology, proudly announces its achievement of an AA rating in the KOSDAQ (Korea Securities Dealers Automated Quotations) technology listing evaluation. Garnering A grades from both...

2024-02-05 22:00 3095

BrainGear Develops SleePYA, the Digital Healthcare for Brain Rehabilitation and Sleep Aid

SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- As startup engaging in digital healthcare business, especially brain rehabilitation and sleep aid, BrainGear has developed SleePYA with infrared light to stimulate the brain to induce quality of sleep.

2024-02-05 22:00 2240

Hico Management Launches 'Hico-Bow Joint Fund', Attracting External LPs. Accelerating AI Investments in the Tech Innovation Hub of Silicon Valley

* Forming a joint fund with the globally renowned VC, Bow Capital * Focusing on early-stage tech startups in the field of AI, Web3, Digital Transformation (DT), healthcare * Holds significance in attracting external LPs... leaping into an independent VC and enhancing investment expertise SEO...

2024-02-01 23:00 3524

Joseph Chang, A Co-CEO Nominee of Kakao Entertainment Selected for 'Billboard 2024 Power 100 List'

SEOUL, South Korea, Feb. 1, 2024 /PRNewswire/ -- Kakao Entertainment announces that its co-CEO nomineeJoseph Chang has been recognized on the 'Billboard 2024 Power 100 List'. Joseph Chang, a co-CEO nominee of Kakao ...

2024-02-01 20:00 2466

SK Networks Collaborates with Vivek to Propel AI-centered Business-oriented Investment Company Through 'SK Networks Renaissance Project'

* Bow Capital Managing Director and NBA Sacramento Kings Owner Visits Korea * MOU to Form Large-Scale Investment Cooperation Consortium for SK Networks Renaissance Project… Investments Target the Purchase of SK Networks' Treasury Stock Alongside Major U.S. Investors * SK Networks Boosts Busi...

2024-02-01 05:00 2888

A Korean UV Sensor Manufacturer, Genicom Introduces Breakthrough Far UV & VUV Optical Sensor for Safe and Efficient Pathogen Control

SEOUL, South Korea, Jan. 31, 2024 /PRNewswire/ -- The COVID-19 pandemic is an ongoing challenge of emerging and re-emerging infectious pathogens. Ultraviolet (UV) has high energy in the wavelength range of 100 ~ 400nm and is used for sterilization, air purification, medical treatment, etc. by bre...

2024-01-31 22:00 2578

COSMAX Established OTC Lab…'Targeting the $2.6 Billion U.S. sun care market'

- Actively responding to its global clients targeting the U.S. sun care market - Strengthening the K-Sunscreen formulations lineup including cushions and sticks - Enhancing its expertise in sun care products through OTC Lab SEONGNAM, South Korea, Jan. 26, 2024 /PRNewswire/ -- COSMAX, a global cos...

2024-01-26 22:00 3774

FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System

SEOUL, South Korea, Dec. 12, 2022 /PRNewswire/ -- RF Medical Co., Ltd. is a premier Korean-based medical company serving the healthcare industry for almost two decades. Recently, FDA cleared RF Medical's patented MYGEN™ M-3004 generator and MYOBLATE™ radiofrequency ablation system.

2024-01-26 15:26 2057

LG Energy Solution Posts Steady Annual Growth, Aims for Continued Advancement Through Qualitative Growth

* LG Energy Solution marks KRW 33.7 trillion in consolidated revenue and KRW 2.2 trillion in operating profit in 2023 * To maintain growth momentum, the company to pursue qualitative growth by securing technology leadership, cost competitiveness and future readiness * This year's guidance fo...

2024-01-26 10:22 3053

SK hynix Reports Financial Results for 2023, 4Q23

- Reports first quarterly profit in a year, backed by demand recovery, industry rebound - Revenues for 2023 at 32.77 trillion won, operating loss at 7.73 trillion won - Aims to grow into 'total AI memory provider' of optimal memory solutions SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- SK hyn...

2024-01-25 07:30 4294

LG Energy Solution to Invest in Promising U.S. Lithium Metal Battery Technology Startup, Solidifying Leadership in Next-Generation Battery Technology

* LG Energy Solution announces equity investment in Sion Power, an Arizona -based startup that holds core patents for lithium metal battery technologies * The latest investment is part of company's dedication to open innovation, joining efforts with competent partners to tackle technological ch...

2024-01-25 07:00 2551

Wellysis Goes Global with ECG Monitor 'S-Patch', Enters US and Indian Markets

SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- Digital healthcare innovator Wellysis is making waves in the global market with its revolutionary electrocardiogram (ECG) monitoring solution, 'S-Patch,' securing strategic partnerships and distribution deals to propel its entry into the lucrative...

2024-01-24 22:00 2762

CES 2024: EDINT's Mobile-based Proctoring Service "Proctormatic" Sets Stage for Global Expansion

DAEJEON, South Korea, Jan. 24, 2024 /PRNewswire/ -- South Korean tech startup EDINT significantly impacted the Consumer Electronics Show (CES) 2024, held fromJanuary 9th to 12th in Las Vegas. The company stood out among the 20 participating companies from Daejeon City at Eureka Park and secured g...

2024-01-24 22:00 3188

LG Innotek accelerating its entry into autonomous driving and XR markets

* Investing in a Taiwanese lens manufacturing corporation to enhance business competitiveness and supply chain. * Entered into a strategic partnership to cooperate in the area of optical components. * CEO Moon Hyuk-soo, "We will provide differentiated customer values with our overwhelming t...

2024-01-24 21:00 2646

Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI

* Results showed partial response being confirmed in 7 out of 42 patients * Partial response was observed in 3 out of 8 patients who were previously treated by immunotherapy SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- Genome & Company (KOSDAQ: 314130), a clinical stage biotech leading in...

2024-01-24 21:00 2504

WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs)

SHANGHAI and INCHEON, South Korea, Jan. 23, 2024 /PRNewswire/ -- WuXi XDC(2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market, and Celltrion, Inc. (068270.KS), a leading global biopharmaceutical...

2024-01-24 11:37 2436

SUMSEI Triumphs at CES 2024, Solidifying Its Position as a Premier Home Appliance Brand Redefining the Intersection of Nature and Technology

* Sensory Engagement: An Immersive Experiential Booth Articulating the Brand Philosophy of 'Nature, Anytime Anywhere' * Earning High Acclaim and Positive Reception for 'Air Shower,' a Pioneering Product in a New Category, and 'In the Forest' SEOUL, South Korea, Jan. 23, 2024 /PRNewswire/ -- S...

2024-01-24 11:11 2335

PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors

* Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 monotherapy and combination therapy with KEYTRUDA® * The clinical trial aims to enroll a total of 67 patients across four institutions inAustralia DAEJEON, South Korea, Jan. 23, 2024 /PRNewswire/ ...

2024-01-24 10:01 2306
1 ... 72737475767778 ... 141